《醫(yī)學(xué)年鑒》是一份國(guó)際的、同行評(píng)審的綜述性雜志，是分子醫(yī)學(xué)和臨床實(shí)踐的橋梁。它提供了當(dāng)前的意見(jiàn)，廣泛的醫(yī)療專業(yè)，以內(nèi)科為重點(diǎn)。這一獨(dú)特的資源使讀者能夠跟上最新的進(jìn)展，了解疾病的發(fā)病機(jī)制和分子醫(yī)學(xué)如何影響日常臨床實(shí)踐的最新進(jìn)展。定期出版有關(guān)臨床實(shí)踐趨勢(shì)和分子醫(yī)學(xué)趨勢(shì)的叢書(shū)。2001年的專題論文將包括腫瘤發(fā)生、肥胖、血管生成和抑郁癥。一個(gè)關(guān)于分子醫(yī)學(xué)最新進(jìn)展的新系列將從分子心臟病學(xué)和分子內(nèi)分泌學(xué)開(kāi)始。《醫(yī)學(xué)年鑒》的影響因子為2.566，在世界醫(yī)學(xué)分類(一般類和內(nèi)部類)中排名12/110。本雜志為芬蘭醫(yī)學(xué)協(xié)會(huì)十二指腸出版。

Annals of Medicine is an international, peer-reviewed review journal bridging molecular medicine and clinical practice. It provides current opinions on a wide range of medical specialties focusing on internal medicine. This unique resource enables readers to keep up-to-date with the latest advances in the understanding of the pathogenesis of diseases and how molecular medicine can impact on daily clinical practice. The series on Trends in Clinical Practice and Trends in Molecular Medicine are published regularly. Special Sections feature commissioned, peer-reviewed papers on different aspects of a theme, which in 2001 will include tumorigenesis, obesity, angiogenesis and depression. A new series on the very latest advances in molecular medicine will start with molecular cardiology and molecular endocrinology. Annals of Medicine has an impact factor of 2.566 and is ranked 12/110 in the world in the category of Medicine, General and Internal. This journal is published for The Finnish Medical Society Duodecim.